Sort
48,018 grants matching “immunotherapy”
Mechanisms of Vaccinia Virus Innate Immune Inhibition
$406,250William Lawrence Marshall · Univ Of Massachusetts Med Sch Worcester · R01 · FY2007 · AI
B Cell Immunity to Hepatitis C Virus
$406,250Steven Foung · Stanford University · R56 · FY2009 · AI
Engineering the Brain Immune System for Tumor Therapy
$406,250Maria G Castro · Cedars-Sinai Medical Center · R01 · FY2009 · NS
LncRNA EPIC1 induces immunotherapy resistance by activating EZH2 in breast cancer
$406,248Da Yang · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Oral IFN-tau treatment in RRMS patients
$406,236Pepgen Corporation · R43 · FY2004 · AI
The role of IL-10 in stabilizing natural regulatory T cells
$406,210Mitchell Kronenberg · La Jolla Institute For Immunology · P01 · FY2011 · AI
Arenavirus Receptor--Structure/Function Studies
$406,145Michael B Oldstone · Scripps Research Institute, The · R01 · FY2007 · AI
Arenavirus Receptor-Structure/Function Studies
$406,144Michael B Oldstone · Scripps Research Institute, The · R01 · FY2009 · AI
IDO1 and Immunotolerance in Glioblastoma
$406,136Derek Alan Wainwright · Northwestern University At Chicago · R01 · FY2020 · NS
Anti-ceramide immunotherapy for diabetic retinopathy
$406,120Julia V Busik · Michigan State University · R01 · FY2019 · EY
Immunophysiological Mechanisms in the Biological Therapy of Cancer
$406,116Robert Wiltrout · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Project 2 - Modulation of Anti-Tumor Immunity by Inhibitory Receptors
$406,094Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2021 · AI
Balancing protective immunity and chronic sequelae by resident CD8 T cells
$406,068Jie Sun · Mayo Clinic Rochester · R01 · FY2021 · AI
Project 1: FLASH vs. Standard radiotherapy for treatment of PDAC and sparing normal intestine tissues
$406,043Constantinos Koumenis · University Of Pennsylvania · P01 · FY2024 · CA
Mechanisms of natural killer cell resistance of treatment-persistent residual tumor cells in hematologic malignancies
$406,038Constantine S. Mitsiades · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Laboratory and Clinical studies on T-cells recognizing NSCLC
$406,033James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
ST8Sia6 expression on tumors inhibits the immune response
$406,002Virginia Smith Shapiro · Mayo Clinic Rochester · R01 · FY2020 · CA
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
$405,983Kenneth P Olive · Columbia University Health Sciences · R01 · FY2025 · CA
Mechanisms of Immune Evasion by Hepatitis C Virus
$405,900Andrea L Cox · Johns Hopkins University · R01 · FY2010 · AI
CHILDRENS CANCER GROUP
$405,880Children'S Hospital Of Philadelphia · U10 · FY2002 · CA
Single-cell and imaging data integration software to spatially resolve the tumor microenvironment
$405,874Elana Fertig · Johns Hopkins University · U01 · FY2020 · CA
HSV-1 TK MODIFIED T CELLS FOR GRAFT VERSUS LEUKEMIA
$405,860University Of Pennsylvania · P50 · FY2000 · HL
Analysis of peripheral tolerance in vivo
$405,856Marc K. Jenkins · University Of Minnesota · P01 · FY2014 · AI
Analysis of peripheral tolerance in vivo
$405,856Marc K. Jenkins · University Of Minnesota · P01 · FY2013 · AI
Mechanisms of immune evasion in T-cell acute lymphoblastic leukemia and its therapeutic implications
$405,748Birgit Knoechel · Dana-Farber Cancer Inst · R01 · FY2021 · CA